518
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescue

, , , , &
Pages 313-331 | Accepted 29 Nov 2011, Published online: 03 Jan 2012

Figures & data

Table 1.  Health states included in the study and associated ranking based on severity.

Table 2.  Summary description by health states of treatment and percentage of subjects experiencing side-effects.

Table 3.  Reporting by health state of percentage of subjects experiencing any feeling, difficulty, or interference of some sort due to their condition.

Figure 1.  Screenshot of the computerized time trade-off questionnaire: on the eQtool.

Figure 1.  Screenshot of the computerized time trade-off questionnaire: on the eQtool.

Figure 2.  Screen shot of the eQTool® depicting Health State 1.

Figure 2.  Screen shot of the eQTool® depicting Health State 1.

Table 4.  Study demographics compared to Canadian national estimates.

Figure 3.  Mean utility scores elicited from the time-trade-off and their corresponding 95%CI. HS, health state; CI, confidence interval. For description of health states, please see .

Figure 3.  Mean utility scores elicited from the time-trade-off and their corresponding 95%CI. HS, health state; CI, confidence interval. For description of health states, please see Table 1.

Table 5.  Utility scores elicited from the time trade-off analysis.

Table 6.  Utility scores: Floor and ceiling effects.

Table 7.  Adjusted utility scores to match general population using direct standardization.

Table 8.  Sensitivity analysis: Outliers removed (values <0.05 and >0.95 are removed).

Table A1.  Exact transcription of the text of the preamble and of the 12 health states as presented to the participants of the Time Trade-Off survey.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.